​

Mangoceuticals Stock (NASDAQ:MGRX)

RevenueFinancialsChart
Mangoceuticals by TradingView

Previous Close

$0.41

52W Range

$0.16 - $2.75

50D Avg

$0.38

200D Avg

$1.18

Market Cap

$4.26M

Avg Vol (3M)

$13.06M

Beta

2.12

Div Yield

-

MGRX Company Profile

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

3

IPO Date

Mar 21, 2023

Website

MGRX Performance

MGRX Financial Summary

Dec 25Dec 24Dec 23
Revenue$304.81K$615.87K$731.49K
Operating Income$-18.03M$-7.97M$-9.22M
Net Income$-20.64M$-8.71M$-9.21M
EBITDA$-18.03M$-7.96M$-8.09M
Basic EPS$-2.05$-4.40$-8.58
Diluted EPS$-2.05$-4.40$-8.58

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
ASBPAspire Biopharma Holdings, Inc.
HCTIHealthcare Triangle, Inc.
FEMYFemasys Inc.
VSEEVSee Health, Inc.
TOIThe Oncology Institute, Inc.
CLSDClearside Biomedical, Inc.
CINGCingulate Inc.
PALIPalisade Bio, Inc.